H|T: The Healthtech Times – AstraZeneca pays $2B for Hamilton biopharma firm
Plus: Neuralink’s first human subject shows off abilities on livestream.
Plus: Neuralink’s first human subject shows off abilities on livestream.
Province hints that the OSC is developing new rules to support angel investors.
Deal is hoped to strengthen Dialogue’s support for women’s healthcare.
Plus: Healthcare startup Tempus preps for IPO.
AstraZeneca says the deal marks “a major step forward” in its goal to transform cancer treatment.
The regional development agency is doling out nearly $14 million.
Startup’s FloPatch product measures blood flow for critically ill patients.
Startup adds Round13, Deloitte, Samsung to fuel efforts to help patients understand their medical images.
Plus: Vancouver looks to join the global big leagues of modern medicine.
Pre-clinical startup discovers drugs that treat inflammatory diseases.
Plus: Myanmar Molecular seeks Health Canada approval.
MedReddie, SkyAcres, and Nimble Science represent Canada in the class of 2024.
Cognito plans to expand its mental health services across Canada this year.
Startup closes $783,000 in pre-seed funding led by HaloHealth.
Healthtech startup recently won $50,000 from the Firehood Angel Camp at SAAS NORTH.